Vigilare Wealth Management
FBT icon

Vigilare Wealth Management’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Vigilare Wealth Management’s Portfolio FBT Stock Details FBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$241K Hold
885
– – 0.07% 108
2026
Q2 		$219K Buy
+885
New +$191K 0.07% 112

Other funds holding FBT

LPL Financial
LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $84.4B AUM 20.16% 1-Year Est. Return
Nilsine Partners
Nilsine Partners Greenwood Village, Colorado $1.44B AUM 38.08% 1-Year Est. Return
D.A. Davidson & Co
D.A. Davidson & Co Great Falls, Montana $18.6B AUM 17.65% 1-Year Est. Return
Bensler
Bensler Bellevue, Washington $1.06B AUM 29.38% 1-Year Est. Return
Csenge Advisory Group
Csenge Advisory Group Clearwater, Florida $2.53B AUM 18.15% 1-Year Est. Return
NewSquare Capital
NewSquare Capital Newtown Square, Pennsylvania $1.38B AUM 24% 1-Year Est. Return
TD Waterhouse Canada
TD Waterhouse Canada Toronto, Ontario, Canada $38.4B AUM 30.28% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $45.2B AUM 20.72% 1-Year Est. Return
Kestra Advisory Services
Kestra Advisory Services Austin, Texas $35.1B AUM 20.13% 1-Year Est. Return

Vigilare Wealth Management's FBT Position: Q3 2026 in Review

Vigilare Wealth Management held its First Trust NYSE Arca Biotechnology Index Fund (FBT) position steady in Q3 2026 at 885 shares worth $241K. The position accounts for 0.07% of the portfolio, ranked #108.

Vigilare Wealth Management first reported a position in FBT in Q2 2026 and has held it in 2 quarters since. 219 funds tracked by Wall St. Rank hold FBT as of Q3 2026.

  • Vigilare Wealth Management held 885 shares of First Trust NYSE Arca Biotechnology Index Fund worth $241K as of Q3 2026.
  • Vigilare Wealth Management left its First Trust NYSE Arca Biotechnology Index Fund share count unchanged in Q3 2026.
  • First Trust NYSE Arca Biotechnology Index Fund made up 0.07% of Vigilare Wealth Management's portfolio in Q3 2026, its #108 holding.
  • Vigilare Wealth Management first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q2 2026 and has held it in 2 quarters since.
  • 219 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q3 2026.

Based on Vigilare Wealth Management's 13F filing for Q3 2026, filed 29 Oct 2026.